Dr. Vivek R. Sharma, MD

Dr. Sharma practices at UofL Health - UofL Hospital in Louisville, Kentucky, part of UofL Health.

Dr. Sharma's NPI, 1144209982, was assigned on January 11, 2006. Dr. Sharma holds Kentucky license 34402.

Dr. Sharma's primary practice is UofL Health - UofL Hospital, at 530 South Jackson Street, Louisville, KY 40202 in Jefferson County. The practice phone is (502) 562-3000.

Dr. Sharma's primary practice is UofL Health - UofL Hospital in Louisville, Kentucky, part of UofL Health. Dr. Sharma is also affiliated with Baptist Health Louisville. The medical group on file is UofL Physicians, Radiology. Dmand AI also links Dr. Sharma to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sharma practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Sharma's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Sharma is licensed in Kentucky.

CMS data shows 533 Medicare services from Dr. Sharma across 5 procedure codes in 2024, for 189 Medicare patients. Medicare paid $40,256 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 189 Medicare patients who saw Dr. Sharma in 2024. The largest group is 65 to 74, with 97 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sharma's median patient age at 70, with 49% women.

In 2024, Dr. Sharma wrote 563 Medicare Part D claims for 92 patients. 84% of them were for generic drugs. CMS names the drug for 420 of them, across 16 drugs with 11 or more claims each, at $108,266 in total drug cost. In 2023, CMS named 635 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Sharma for performance year 2024, reported as part of a group. Dr. Sharma accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 21 papers to Dr. Sharma, published from 2011 to 2024. 2020 was the busiest year, with 3. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Camptothecin and Irinotecan. Dr. Sharma has published most often in Ann Hematol. Dr. Sharma's most frequent co-authors are Clifton Tatum, MD, Ali Cahid Civelek, MD and Todd Shane Crocenzi, MD.

Dmand AI links Dr. Sharma to 7 clinical trials, 3 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Blushing, Colonic Neoplasms and Hemoglobinuria. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Sharma that name 1 trial.

CMS Open Payments shows 1,251 general payments to Dr. Sharma from 60 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 65% of the total. Sanofi and Genzyme US Companies paid the most, $269,683. It also lists 3 research payments totaling $15,865 from 2016 to 2021, naming 1 clinical trial.